Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis

NCT06360861 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis
Secondary-Progressive Multiple Sclerosis
Mesenchymal Stem Cells

Interventions

BIOLOGICAL: Allogenic placenta derived mesenchymal stem cells

Sponsor

Tehran University of Medical Sciences